Form 8-K - Current report:
SEC Accession No. 0001104659-25-023447
Filing Date
2025-03-13
Accepted
2025-03-13 16:05:13
Documents
14
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259112d1_8k.htm   iXBRL 8-K 27594
2 EXHIBIT 99.1 tm259112d1_ex99-1.htm EX-99.1 69809
  Complete submission text file 0001104659-25-023447.txt   279438

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20250313.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20250313_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20250313_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm259112d1_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 25735705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)